Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical triamcinolone on the dura mater for pain control after lumbar fusion surgery
IRCT20250315065081N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of triamcinolone acetonide in postoperative pain (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Average pain intensity and Pain intensity in recovery. Started Jun 2025; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20250315065081N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250315065081N1.